GLP-1 therapy is a very effective and well-established treatment for T2D and obesity in clinic [7]; however, the molecular mechanisms of how GLP-1 is secreted in physiological nutrient condition is unclear. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.